Does neuropathy develop in animal models?

Clinical Neuroscience

Volumn 4, Issue 6, 1997, Pages 380-389

  Hounsom, Luke ^b   Tomlinson, David R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

Animal models; Diabetic neuropathy; Human; Streptozotocin

Indexed keywords

SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; MOTOR NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STREPTOZOCIN DIABETES;

ANIMALS; AXOTOMY; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; GLYCOSYLATION; HUMANS; NERVE GROWTH FACTORS; SORBITOL;

EID: 0030690303     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Anand P, Terenghi G, Warner G, Kopelman G, Williams-Chestnut RE, Sinicropi DV (1996): The role of endogenous nerve growth factor in human diabetic neuropathy. Nature Med 2:703-707.
2. Appenzeller O, Dhital KK, Cowen T, Burnstock G (1984): The nerves to blood vessels supplying blood to nerves: The innervation of vasa nervorum. Brain Res 304:383-386.
3. Bagnasco SM, Balaban R, Fales HM, Yang Y-M, Burg M (1986): Predominant osmotically active solutes in rat and rabbit renal medullas. J Biol Chem 261:5872-5877.
4. Beggs J, Johnson PC, Olafsen A, Watkins CJ, Cleary C (1991): Transepineurial arterioles in human sural nerve. J Neuropathol Exp Neurol 50:704-718.
5. Behse F, Buchthal F, Carlsen F (1977): Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 40:1072-1082.
6. Blanco R, Saenz de Tejada I, Goldstein I, Krane RJ, Wotiz HH, Cohen RA (1990): Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol 144:278-280.
7. Boulton AJM, Armstrong W, Scarpello JHB, Ward JD (1983): The natural history of painful diabetic neuropathy, a four year study. Postgrad Med J 59:556-559.
8. Britland ST, Young RJ, Sharma AK, Clarke BF (1990): Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 39:909-913.
9. Brown MJ, Asbury AK (1984): Diabetic neuropathy. Ann Neurol 15:2-12.
10. Brownlee M (1994): Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 43:836-841.
11. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A (1986): Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632.
12. Buck AC, Reed PI, Siddiq YK, Chisholm GD, Fraser TR (1976): Bladder dysfunction and neuropathy in diabetes. Diabetologia 12:251-258.
13. Cameron NE, Cotter MA, Low PA (1991): Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits. Am J Physiol 261:E1-E8.
14. Chakrabarti S, Sima AAF, Nakajima T, Yagihashi S, Greene DA (1987): Aldose reductase in the BB rat: Isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 30:244-251.
15. Chopra JS, Fannin T (1971): Pathology of diabetic neuropathy. J Pathol 104:175-184.
16. Chopra JS, Hurwitz LJ (1969): A comparative study of peripheral nerve conduction in diabetes and nondiabetic chronic occlusive peripheral vascular disease. Brain 92:83-90.
17. Chopra JS, Connon JJ, Banerji NK (1969): Diabetic neuropathy - clinical and electrophysiological study in synalbumin positive and synalbumin negative subjects. Diabetologia 5:413-415.
18. Chopra JS, Sawhney BB, Chakravorty RN (1977): Pathology and time relationship of peripheral nerve changes in experimental diabetes. J Neurol Sci 32:53-67.
19. Christensen JEJ, Varnek L, Gregersen G (1985): The effect of an ARI (Sorbinil) on diabetic neuropathy and neural function of the retina: A double-blind study. Acta Neurol Scand 71:164-167.
20. Clements RS (1979): Diabetic neuropathy - new concepts of its etiology. Diabetes 28:604-611.
21. Cullum NA, Mahon J, Stringer K, McLean WG (1991): Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia 34:387-389.
22. Dahl-Jorgensen K (1987): Near-normoglycemia and late diabetic complications. The Oslo Study. Acta Endocrinol 284:1-38.
23. Dhital K, Lincoln J, Appenzeller O, Burnstock G (1986): Adrenergic innervation of vasa and nervi nervorum of optic, sciatic, vagus and sympathetic nerve trunks in normal and streptozotocin-diabetic rats. Brain Res 367:39-44.
24. Diabetes Control and Complications Trial Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng J Med 329:977-986.
25. Downie AW, Newell DJ (1961): Sensory nerve conduction in patients with diabetes mellitus and controls. Neurology 11:876-884.
26. Dvornik D, Simard-Duquesne N, Krami M, Sestanj K, Gabbay KH, Kinoshita JH, Varma SD, Merola LO (1973): Polyol accumulation in galactosemic and diabetic rats: Control by an aldose reductase inhibitor. Science 182:1146-1148.
27. Dyck PJ (1996): Nerve growth factor and diabetic neuropathy. Lancet 348:1044-1045.
28. Dyck PJ, Hansen S, Karnes J, O'Brien PC, Yasuda H, Windebank AJ, Zimmerman BR (1985): Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 82:2513-2517.
29. Dyck PJ, Lais A, Karnes JL, O'Brien PC, Rizza RA (1986): Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425-439.
30. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien PC, Service FJ (1987): Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 10:432-440.
31. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF (1988): Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. New Eng J Med 319:542-548.
32. Fagerberg SE (1959): Diabetic neuropathy, a clinical and histological study on the significance of vascular affection. Acta Med Scand 345:1-97.
33. Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA (1983): Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy. Diabetes 32:988-992.
34. Gabbay KH, Merola LO, Field RA (1966): Sorbitol pathway: Presence in nerve and cord with substrate accumulation in diabetes. Science 151:209-210.
35. Gillon KRW, Hawthorne JN, Tomlinson DR (1983): Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibition. Diabetologia 25:365-371.
36. Gold BG, Mobley WC, Matheson SF (1991): Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. J Neurosci 11:943-955.
37. Gonen B, Bochenek WJ, Beg M, Graepel GJ (1991): The effect of withdrawal of tolrestat, an aldose reductase inhibitor, on signs, symptoms and nerve function in diabetic neuropathy. Diabetologia 34 Suppl. 2:A153.
38. Greenbaum D, Richardson PC (1964): Pathological observations on six cases of diabetic neuropathy. Brain 87:201-210.
39. Greene DA, Winegrad AI (1979): In vitro studies of the substrates for energy production and the effects of insulin on glucose utilization in the neural components of peripheral nerve. Diabetes 28:878-887.
40. Greene DA, De Jesus PVJ, Winegrad AI (1975): Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J Clin Invest 55:1326-1336.
41. Gregersen G (1967): Diabetic neuropathy: Influence of age, sex, metabolic control and duration of diabetes on motor conduction velocity. Neurology 17:972-980.
42. Gregersen G (1968): Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients. Diabetologia 4:273-277.
43. Gregersen G, Borsting H, Theil P, Servo C (1978): Myoinositol and function of peripheral nerves in human diabetics. A controlled clinical trial. Acta Neurol Scand 58:241-248.
44. Grover-Johnson NM, Baumann FG, Imparato AM, Kim GE, Thomas PK (1981): Abnormal innervation of lower limb epineurial arterioles in human diabetes. Diabetologia 20:31-38.
45. Gugliucci A, Bendayan M (1995): Reaction of advanced glycation endproducts with renal tissue from normal and streptozotocin-induced diabetic rats: An ultrastructural study using colloidal gold cytochemistry. J Histochem Cytochem 43:591-600.
46. Hendriksen PH, Oey PL, Wieneke GH, van Huffelen AC, Gispen WH (1992): Hypoxic neuropathy versus diabetic neuropathy: An electrophysiological study in rats. J Neurol Sci 110:99-106.
47. Horrobin DF, Julu PO, Jamal GA (1988): Gamma linolenic acid as a treatment for diabetic neuropathy and other diabetic complications. Diabetes Res Clin Pract 5:S57.
48. Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Komori H, Sakamoto N (1992): Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats. Diabetes 41:587-591.
49. Ikenaka K, Nakahira K, Takayama C, Wada K, Hatanaka H, Mikoshiba K (1990): Nerve growth factor rapidly induces expression of the 68-kDa neurofilament gene by posttranscriptional modification in PC12h-R cells. J Biol Chem 265:19782-19785.
50. Jakobsen J (1976a): Axonal dwindling in early experimental diabetes. I. A study of cross sectioned fibres. Diabetologia 12:539-546.
51. Jakobsen J (1976b): Axonal dwindling in early experimental diabetes. II. A study of isolated nerve fibres. Diabetologia 12:547-553.
52. Jakobsen J, Lundbæk K (1976): Neuropathy in experimental diabetes: An animal model. Br Med J 2:278-279.
53. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D (1981): Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 30:797-803.
54. Jefferys JGR, Palmano KP, Sharma AK, Thomas PK (1978): Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats. J Neurol Neurosurg Psych 41:333-339.
55. Jongstra-Bilen J, Coblentz L, Shooter EM (1989): The in vitro processing of the NGF precursors by the gamma-subunit of the 7S NGF complex. Brain Res Mol Brain Res 5:159-169.
56. Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadinovic C, Bernstein L, Schneider M, Liang KY, Gabbay KH, Rubenstein AH, Porte D (1983): Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. New Eng J Med 308:119-125.
57. Julu POO, Mutamba A (1991): Comparison of short-term effects of insulin and essential fatty acids on the slowed nerve conduction of streptozotocin diabetes in rats. J Neurol Sci 106:56-59.
58. Kaneko S, Bradley WE (1987): Penile electrodiagnosis. Value of bulbocavernosus reflex latency versus nerve conduction velocity of the dorsal nerve of the penis in diagnosis of diabetic impotence. J Urol 137:933-935.
59. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS (1990): Effects of pancreatic transplantation on diabetic neuropathy. New Engl J Med 322:1031-1037.
60. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA (1991): Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 88:6107-6111.
61. Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y, Terashima H, Morimura T, Tsuboshima M (1983): Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-((2E)-methyl-3-phenylpropenylidene)rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia 24: 290-292.
62. Lawrence DG, Locke S (1961): Motor nerve conduction velocity in diabetes. Arch Neurol 5:483-490.
63. Lindenbaum MH, Carbonetto ST, Grosveld F, Flavell D, Mushynski WE (1988): Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC-12 cells. J Biol Chem 263:5662-5667.
64. Lindsay RM, Harmar AJ (1989): Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337:362-364.
65. Low PA (1987): Recent advances in the pathogenesis of diabetic neuropathy. Muscle Nerve 10:121-128.
66. Ludvigson MA, Sorenson RL (1980): Immunohistochemical localization of aldose reductase. I. Enzyme purification and antibody preparation - localization in peripheral nerve, artery and testis. Diabetes 29:438-449.
67. Luzzi S, Zilletti L (1983): Neurological disorders of the myenteric plexus: A review. Riv Patol Nerv Ment 104:229-240.
68. Malik RA (1990): Correlation entre microangiopathie et pathologie nerveuse. Diabete Metab 16:364-366.
69. Mayer JH, Tomlinson DR (1983): Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25:433-438.
70. McLean WG, Pekiner C, Cullum NA, Casson IF (1992): Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes. Mol Neurobiol 6:225-237.
71. Medori R, Autilio-Gambetti L, Monaco S, Gambetti P (1985): Experimental diabetic neuropathy: Impairment of slow transport with changes in axon cross-sectional area. Proc Natl Acad Sci USA 82:7716-7720.
72. Medori R, Autilio-Gambetti L, Jenich H, Gambetti P (1988): Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy. Neurology 38:597-601.
73. Mendell JR, Sahenk Z, Warmolts JR, Marshall JK, Thibert P (1981): The spontaneously diabetic BB Wistar rat. Morphologic and physiologic studies of peripheral nerve. J Neurol Sci 52:103-115.
74. 18 fatty acids on phosphoinositide turnover in cultured human umbilical vein endothelial cells. Biochem Soc Trans 17:93.
75. Miyata T, Ueda Y, Shinzato T, Lida Y, Tanaka S, Kurokawa K, De Strihou CV, Maeda K (1996): Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206.
76. Monnier VM (1996): Aminoguanidine and diabetic neuropathy. Eur J Endocrinol 134:398-400.
77. Mulder DW, Lambert EH, Bastron JA, Spragur RG (1961): The neuropathies associated with diabetes mellitus: A clinical and electomyographic study of 103 unselected diabetic patients. Neurology 11:275-286.
78. Newrick PG, Wilson AJ, Jakubowski JA, Boulton AJM, Ward JD (1986): Sural nerve oxygen tension in diabetes. Br Med J 293:1053-1054.
79. Nielsch U, Keen P (1989): Reciprocal regulation of tachykinin- and vasoactive intestinal peptide-gene expression in rat sensory neurones following cut and crush injury. Brain Res 481:25-30.
80. Nishimura C, Lou MF, Kinoshita JH (1987): Depletion of myo-inositol and amino acids in galactosemic neuropathy. J Neurochem 49:290-295.
81. Norido F, Canella R, Gorio A (1983): Functional and morphological abnormalities induced by ouabain intoxication of the rabbit retina. Acta Neuropathol 62:41-45.
82. Norido F, Canella R, Zanoni R, Gorio A (1984): Development of diabetic neuropathy in the C57BL/Ks (db/db) mouse and its treatment with gangliosides. Exp Neurol 83:221-232.
83. O'Hare JP, Morgan MH, Alden P, Chissel S, O'Brien IAD, Corrall RJM (1988): Aldose reductase inhibition in diabetic neuropathy: Clinical and neurophysiological studies of one year's treatment with sorbinil. Diabet Med 5:537-542.
84. Oates PJ (1994): Diabetic nephropathy, renal hemodynamics, and aldose reductase inhibitors. Drug Dev Res 32:104-116.
85. Olsson Y, Save-Soderbergh J, Sourander P, Angervall LA (1968): Patho-anatomical study of the central and peripheral nervous system in diabetes of early onset and long duration. Pathol Eur 3:62-79.
86. Omawari N, Dewhurst M, Vo PA, Mahmood S, Stevens E, Tomlinson DR (1996): Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: Effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil. Br J Pharmacol 118:186-190.
87. Pekiner C, Cullum NA, Hughes JN, Hargreaves AJ, Mahon J, Casson IF, McLean WG (1993): Glycation of brain actin in experimental diabetes. J Neurochem 61:436-442.
88. Perísíc M, Cuénod M (1972): Synaptic transmision depressed by colchicine blockade of axoplasmic flow. Science 175:1140-1142.
89. Pfeiffer A, Schatz H (1995): Diabetic microvascular complications and growth factors. Exp Clin Endocrinol 103:7-14.
90. Powell HC, Costello ML, Myers RR (1981): Endoneurial fluid pressure in experimental models of diabetic neuropathy. J Neuropathol Exp Neurol 40:613-624.
91. Rechtland E, Hervonen A, Sato S, Rapoport SI (1986): Distribution of adrenergic innervation of blood vessels in peripheral nerve. Brain Res 374:185-189.
92. Robinson JP, Willars GB, Tomlinson DR, Keen P (1987): Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Brain Res 426:339-348.
93. Robison WG, Jr., Laver NM, Jacot JL, Glover JP, Basso MD, Blouin P, Hohman TC (1996): Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509. Invest Ophthalmol Vis Sci 37:1149-1156.
94. Roy TM, Broadstone VL, Peterson HR, Snider HL, Cyrus J, Fell R, Rothchild AH, Samols E, Pfeifer MA (1990): The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus. Diabetes Res Clin Pract 10:91-97.
95. Said G, Slama G, Selva J (1983): Progressive degeneration of axons in small fibre type diabetic polyneuropathy. A clinical and pathological study. Brain 106:791-807.
96. Sarica Y, Karacan I (1987): Bulbocavernosus reflex to somatic and visceral nerve stimulation in normal subjects and in diabetics with erectile impotence. J Urol 138:55-58.
97. Schiff HI (1982): The neurogenic bladder in diabetes. NY State J Med 82:922-926.
98. Sharma AK, Thomas PK (1987): Animal Models: Pathology and Pathophysiology. In Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds): Diabetic Neuropathy Section VI Pathology and Pathophysiology - Human and Experimental. Philadelphia: WB. Saunders, pp 237-252.
99. Sima AAF (1983): The development and structural characterisation of the neuropathies in the spontaneously diabetic BB wistar rat. Metabolism 7:106-111.
100. Sima AAF, Hinton D (1983): Hirano-bodies in the distal symmetric polyneuropathy of the spontaneously diabetic BB-wistar rat. Acta Neurol Scand 68:107-112.
101. Sima AAF, Lorusso AC, Thibert P (1982): Distal symmetric polyneuropathy in the spontaneously diabetic BB-wistar rat. An ultrastructural and teased fiber study. Acta Neuropathol 58:39-47.
102. Sima AAF, Bril V, Nathaniel V, McEwen TAT, Brown MB, Lattimer SA, Greene DA (1988a): Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. New Eng J Med 319:548-555.
103. Sima AAF, Zhang W-X, Tze WJ, Tai J, Nathaniel V (1988b): Diabetic neuropathy in STZ-induced diabetic rat and effect of allogencic islet cell transplantation. Morphometric analysis. Diabetes 37:1129-1136.
104. Skillman TG, Johnson EW, Hamwi GJ, Driskill HJ (1961): Motor nerve conduction velocity in diabetes mellitus. Diabetes 10:46-52.
105. Smith WJ, Tomlinson DR, Walker JH, Keen P (1990): Altered neuropeptide gene expression in experimental diabetes. Br J Pharmacol 100:430P.
106. Stewart MA, Sherman WR, Kurien MM, Moonsammy GI, Wisgerhof M (1967): Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosaemia. J Neurochem 14:1057-1066.
107. Sundkvist G, Lilja B, Rosen I, Agardh CD (1987): Autonomic and peripheral nerve function in early diabetic neuropathy. Possible influence of a novel aldose reductase inhibitor on autonomic function. Acta Med Scand 221:445-453.
108. Takmann W, Vogel P, Porst H (1987): Somatosensory evoked potentials after stimulation of the dorsal penile nerve: Normative data and results from 145 patients with erectile dysfunction. Eur Neurol 27:245-250.
109. Thomas PK (1992): Diabetic neuropathy: Models, mechanisms and mayhem. Can J Neurol Sci 19:1-7.
110. Thomas PK, Lascelles RG (1966): The pathology of diabetic neuropathy. Quart J Med 35:489-509.
111. Thomas PK, Tomlinson DR (1992): Diabetic and hypoglycaemic neuropathy. In Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds): Peripheral Neuropathy. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: W.B. Saunders Co. pp 1219-1250.
112. Timperley WR, Ward JD, Preston FE, Duckworth T, O'Malley BC (1976): Clinical and histological studies in diabetic neuropathy: A reassessment of vascular factors in relation to intravascular coagulation. Diabetologia 12:237-243.
113. Tomlinson DR, Holmes PR, Mayer JH (1982): Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett 31:189-193.
114. Tomlinson DR, Moriarty RJ, Mayer JH (1984): Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Diabetes. 33:470-476.
115. Tomlinson DR, Robinson JP, Willars GB, Keen P (1988): Deficient axonal transport of substance P in streptozocin-induced diabetic rats. Effects of sorbinil and insulin. Diabetes 37:488-493.
116. Tomlinson DR, Stevens EJ, Diemel LT (1994): Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol Sci 15:293-297.
117. Tuck RR, Schmelzer JD, Low PA (1984): Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107:935-950.
118. van Heyningen R (1959): Formation of polyols by the lens of the rat with 'sugar' cataracts. Nature 184:194-195.
119. Verge VMK, Tetzlaff W, Bisby MA, Richardson PM (1990): Influence of nerve growth factor on neurofilament gene expression in mature primary sensory neurons. J Neurosci 10:2018-2025.
120. Verge VMK, Merlio J-P, Grondin J, Ernfors P, Persson H, Riopelle RJ, Hokfelt T, Richardson PM (1992): Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci 12:4011-4022.
121. Vital C, Vallat JM, LeBlanc MF, Cocquet M (1973): Peripheral neuropathies caused by diabetes mellitus. Ultrastructural study of 12 biopsied cases. J Neurol Sci 18:381-398.
122. Vital C, LeBlanc M, Vallat JM, Cocquet M, Vallat M, Roques JC (1974): Ultrastructural study of peripheral nerve in 16 diabetics without neuropathy. Comparison with 16 diabetic neuropathies and 16 non-diabetic neuropathies. Acta Neuropathol 30:63-72.
123. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM (1996): Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy - Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97:238-243.
124. Whiteley SJ, Tomlinsori DR (1985): Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes. Exp Neural 89:314-321.
125. Willars GB, Lambourne JE, Tomlinson DR (1987): Does galactose feeding provide a valid model of the consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes? Diabetes 36:1425-1431.
126. Willars GB, Townsend J, Tomlinson DR, Compton AM, Churchill RD (1988): Studies on peripheral nerve and lens in long-term experimental diabetes: Effects of the aldose reductase inhibitor statil. Metabolism 37:442-449.
127. Williams E, Timperley WR, Ward JD, Duckworth T (1980): Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 33:462-470.
128. Yagihashi S, Kamijo M, Ido Y, Mirrlees DJ (1990a): Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy: Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats. Diabetes 39:690-696.
129. Yagihashi S, Kamijo M, Watanabe K (1990b): Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am J Pathol 136:1365-1373.
130. Yagihashi S, Kamijo M, Baba M, Yagihashi N, Nagai K (1992): Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41:47-52.
131. Yasuda H, Dyck PJ (1987): Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37:20-28.
132. Young RJ, Ewing DJ, Clarke BF (1983): A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes 32:938-942.
133. Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF (1986): Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 35:192-197.
134. Yue DK, Hanwell MA, Satchell PM, Turtle JR (1982): The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes 31:789-794.